Article
Adjuvant radiotherapy for primary breast cancer in BRCA1 and BRCA2 mutation carriers and risk of contralateral breast cancer with special attention to patients irradiated at younger age.
Breast cancer research and treatment - 1 Nov 2015
Drooger Jan, Akdeniz Delal, Pignol Jean-Philippe, Koppert Linetta B, McCool Danielle, Seynaeve Caroline M, Hooning Maartje J, Jager Agnes
Abstract excerpt
The purpose of this study was to estimate the influence of adjuvant radiotherapy for primary breast cancer (BC) on the risk of contralateral BC (CBC) in BRCA1 or BRCA2 (BRCA1/2) mutation carriers, with special attention to patients irradiated at age younger than 40 years. Additionally, tendencies in locoregional treatments and rates of contralateral risk-reducing mastectomy over time were explored. In this...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.